Infectious disease is the presence and growth of pathogenic biological agents within a host, usually resulting in a clinically evident illness. Pathogenic biological agents include bacteria, viruses, fungi and parasites. Many pathogens have a very long history with the human species, with several having an association with primates long predating the evolution of *Homo sapiens*. Humans and pathogens have therefore evolved together and had a great influence on each other. Because human and pathogen history is so intertwined, much fascinating information can be learnt about ancient humans by studying ancient pathogens.

For thousands of years North and South America have been home to different human populations. Prior to European contact in 1492, these populations lived in the Americas effectively isolated from the rest of the world. This resulted in very different societies and human infectious diseases developing in the Eastern and Western Hemispheres. There are written records of many of the past human infectious diseases of Eurasia, but due to the destruction by European colonialists, it is not known if there were ever any local records of past human infectious diseases of the Americas. To investigate these diseases we therefore have to investigate ancient human remains through paleopathological and, more recently, paleomicrobiological studies. Paleomicrobiology is an interdisciplinary subject that necessarily overlaps with biology, archaeology, history and anthropology to investigate past infectious diseases ([@B30]). Here, paleomicrobiological studies of the Americas are reviewed to determine what they can tell us about the pre-colonial history of the indigenous peoples of the Americas. Many earlier authors have explored this topic ([@B70], [@B86], [@B73], [@B43], [@B4], [@B39], [@B47]) and have laid the foundation for this review.

Infectious disease transmission occurs between humans in a variety of ways, ranging from inhalation of infected moisture droplets, faecal-oral transmission, infection of wounds from the environment, to transmission *via* an insect vector. Population density, association with animals, proximity of living areas to water sources and human waste, trade links, genetic susceptibility and the use of agricultural methods such as irrigation influence the infectious diseases that occur in the human population. For example, a disease such as tuberculosis that is dependent on respiratory transmission needs a large dense human population to be successfully maintained and transmitted.

It is generally believed that humans first migrated to the Americas approximately 13,000 years ago *via* the Bering Land Bridge (Beringia) while sea levels were significantly low. The humans who first arrived on the landmass that came to be known as North and South America were battling against infectious diseases they brought with them from Asia and those they acquired in the Americas. The aim is not to discuss in depth every pathogen that plagued the pre-colonial Americas, so this review uses selected infectious diseases as examples of the different relationships between humans and their environment. The first of two sections discusses "heirloom" infectious diseases brought to the Americas by the humans that first migrated there and focuses on two selected pathogens, *Helicobacter pylori* and *Mycobacterium tuberculosis*. The second section discusses diseases associated with the local environment, based on two pathogens, *Trypanosoma cruzi* and *Coccidioides immitis*, that began infecting humans after they settled in the Americas, causing "souvenir" infectious diseases ([@B55]).

*Paleomicrobiological methods* - An important method to investigate ancient infectious diseases is the analysis of microbial ancient DNA (aDNA) by the polymerase chain reaction (PCR). PCR revolutionised paleomicrobiological research because it enables trace amounts of fragmented microbial aDNA to be identified and amplified. Thermal cycling is used to amplify aDNA. DNA polymerase and primers - short oligonucleotides that flank a specific target *locus* in the DNA of the pathogen being investigated - are the basis of the method. Microbial aDNA is only preserved under suitable environmental conditions such as low temperatures, dryness and absence of sunlight ([@B30]).

Initially, bacterial pathogens were investigated using PCR targets present as multiple copies in every cell. The same approach can be used for eukaryotic pathogens, such as flagellated protozoa, where the kinetoplast provides an excellent target region ([@B15]). Other studies examine nuclear or mitochondrial DNA. As PCR is such a sensitive technique there is great danger of contamination by modern DNA either from the site or the laboratory. It is therefore essential to use procedures to prevent contamination ([@B31]) including wearing protective clothing, physical isolation of the work area, removal of the surface layer of samples, consideration of past studies that have occurred in the laboratory and the use of negative control amplifications to detect contamination. Results should be reproducible in other laboratories using the same contamination control procedures.

Today, next generation sequencing, or whole genome sequencing, reduce the risk of contamination, as there is no DNA amplification ([@B32]). Extracted DNA is fragmented, end-repaired and tagged, prior to analysis by high throughput sequencers. When analysing aDNA, DNA fragment size gating can eliminate any contaminating modern DNA. The use of magnetic beads or microarrays coated with single-stranded DNA from a target genome can enrich aDNA recovery. The resulting sequences are aligned and bioinformatics analysis used to identify all the genomes present in a sample.

The samples for paleomicrobiological analyses can come from many different locations in ancient human remains, mineralised or mummified. Microbial aDNA can occur in the dental pulp of teeth, bone, mummified tissues ([@B33]) or coprolites. Bodies may be mummified naturally or by human intervention. As mentioned by [@B83], naturally mummified individuals are often more suitable for bacterial DNA studies because the absence of any embalming processes leaves the local environment in the tissues unchanged. Coprolites are fossilised faeces that are useful sources of pathogen aDNA, especially for investigations of intestinal parasites ([@B9]).

The mycobacteria, including the *M. tuberculosis* complex, have some unique features that facilitate the persistence of their aDNA. These microbes have DNA with a high proportion of guanine and cytosine that increases its stability and thick lipid-rich cell walls. The bacterial cell walls protect the microbial DNA from the lytic enzymes of the host cell when undergoing autolysis or necrosis. Both these features enable the direct detection and characterisation of aDNA and lipid biomarkers of *M. tuberculosis* in ancient specimens. Indeed, the use of whole genome sequencing has confirmed that *M. tuberculosis* aDNA is better preserved than human aDNA in the same specimens ([@B25]). Therefore, information can sometimes be gained from human remains based on the infecting *M. tuberculosis* aDNA rather than host aDNA.

[@B85] described the variety of methods to diagnose ancient disease using techniques other than the analysis of aDNA via PCR. Biomolecules such as mycolic acids (of mycobacteria) and proteins can be detected in ancient specimens using immunohistochemistry, immunochromatography and ELISA techniques. Protein detection by mass spectroscopy and immuno-PCR are other potentially useful techniques. As with DNA analysis by PCR, strict protocols must be followed to avoid contamination and ensure authenticity of data.

The direct observation of ancient human material remains an important technique to diagnose ancient infectious disease, but was especially so before the invention of molecular methods. Observations include the direct detection of parasites in human remains or the paleopathology caused by the presence of the pathogen. For example, a pre-Columbian mummy of a young man in southern Peru had numerous granulomatous lesions and vesicles on his skin. Giemsa staining and microscopy showed typical clumps of bacilli with morphology similar to *Bartonella bacilliformis*, the cause of Carrión's disease, spread by sandflies, that results in acute fatal anaemia or a condition known as verruga - characterised by wart-like lesions ([@B2]). Many pathogens, including *M. tuberculosis*, trigger visible skeletal lesions in human remains and such material was used in the first study to diagnose ancient tuberculosis by the detection of pathogenic bacterial aDNA ([@B81]). Skeletal observations are essential when DNA analysis and other biomolecular methods are inconclusive, but are often problematic because different diseases can cause similar skeletal changes. Therefore paleopathology alone may give insufficient evidence to diagnose a disease. Ideally, morphological observation and biomolecular methods should be used to complement each other and strengthen the evidence that a particular pathogen was present. Dating of ancient specimens is a very important part of paleomicrobiological research. A variety of methods are used, including the investigation of artefacts associated with the remains, the archaeological and architectural features of the surrounding area, the stratigraphic provenance of the remains and radiocarbon dating of the skeletons themselves and associated organic matter.

*Heirloom human infectious diseases in the Americas* - This section discusses human infectious diseases brought to the Americas with the humans that first migrated there. Heirloom human infectious diseases are caused by bacteria, viruses or parasites ([@B5]), which have evolved with humans in Africa, Europe and Asia. There are many studies and reviews of the paleoparasitology of the Americas, including protozoa ([@B69], [@B27]), roundworms ([@B7], [@B59]), pinworms ([@B52]), fleas and lice ([@B74], [@B29]). However, there are far fewer reports of viral ([@B42], [@B60]) or bacterial infections. [@B11] used the distribution of head lice (*Pediculus humanus capitis*) in archaic mummies from northern Chile as a bioindicator of cultural behaviour, as the lice are associated with crowded living conditions. The human head louse has also given insights into migration and the human colonisation of the New World ([@B13]). [@B88] reviewed the association of various microbes with their host and examined the most appropriate candidates that can act as markers to enable human migrations to be tracked. They concluded that the best example was *H. pylori*. Recent advances in understanding the genomics and genetic lineages of *H. pylori* and another pathogen with close links to human lineages, *M. tuberculosis*, are highlighted below.

*H. pylori* - *Human migration into the Americas* - *H. pylori* is a Gram-negative bacterium. It can be used as a marker of prehistoric human migrations because it has been associated with humans throughout human evolution. Indeed, bacteria related to *H. pylori* are found in non-human primates and other mammals, indicating the long history of co-evolution with mammalian species. Due to this long association with *H. pylori*, human gastric physiology has evolved so that the presence of the bacterium is advantageous in some ways and may protect the human stomach from other bacterial infections ([@B14]). Human transmission of the bacterium is not well understood, but is believed to most often occur between humans via the oral-oral or the faecal-oral route.

A study by [@B62] using a large dataset of modern *H. pylori* DNA sequences has revealed that, as with humans, the genetic diversity of *H. pylori* decreases with geographical distance from East Africa. This indicates that the first humans, who evolved in East Africa, were infected with *H. pylori* prior to their migrations out of this area 58,000 years ago. The findings of [@B34] support this research, as they showed that bacterial sequences of one virulence-associated gene (*vacA*) and fragments of seven housekeeping genes differ according to the continent in which they are found and the human population with which they are associated.

Ancient strains of *H. pylori* have been identified in human remains discovered in the Americas. The first discovery, in a mummified individual from the funeral cave of La Ventana in Chihuahua State desert in Mexico, dated to approximately 1350 AD ([@B24]). Pre-Columbian *H. pylori* was confirmed by 16S *rRNA* DNA sequences. The second discovery, by [@B83], was based on a Kwäday Dän Ts'ìnchi individual found in the Samuel Glacier in Tatshenshini-Alsek Park in British Columbia in Canada, from the late XVII and mid-XIX centuries. The *H. pylori* DNA amplified from the stomach of the Kwäday Dän Ts'ìnchi individual contained a *vacA* m2a/m1d allele associated with indigenous American strains, but also a *vacA* s2 allele, rare in Asian strains, but commonly associated with European strains. The Kwäday Dän Ts'ìnchi individual was radiocarbon dated to approximately 1670-1850 AD, a time after European contact with the Americas. Therefore the most likely reason that the European and indigenous American regions are present in bacteria amplified from this individual is because there were Europeans present in Canada during the individual's lifetime and the *H. pylori* bacteria in the Kwäday Dän Ts'ìnchi individual are therefore hybrids. Both these *H. pylori* findings in these historical individuals therefore support the theory that humans first migrated to the Americas from Asia. The Mexican mummy was dated to approximately 1350 AD, a time prior to European contact with the Americas, so the evidence that humans first migrated to the Americas from Asia is especially strong from this source.

[@B89] analysed modern strains of *H. pylori* associated with indigenous peoples of the Americas, based on variations in the alleles *vacA*, *cagA* - part of the *cag* pathogenicity island in the *H. pylori*genome and the right end of the *cag* pathogenicity island. They found that some native Colombian and Alaskan strains possessed novel *vacA* and/or *cagA* gene structures and were more closely related to East Asian than to non-Asian *H. pylori*. Also, some native Alaskan strains appear to have originated in Central Asia and to have arrived after strains found in South America suggesting that *H. pylori* crossed the Bering Strait from Asia to the New World at different times.

In a study of another modern population, a group of Amerindian subjects from Amazonia, East Asian *H. pylori*genotypes were present for each of the *loci* examined, but were absent in a mestizo population from Caracas. These findings provide evidence that *H. pylori*has been present in humans at least since ancestors of Amerindians migrated from Asia more than 11,000 years ago ([@B44]). A more recent study of modern strains from Mexico ([@B23]) showed that Mexican indigenous people with Amerindian markers are colonised with *H. pylori* showing an admixture of Asian, European and African strains in genes known to interact with the gastric mucosa. In addition, evidence was found of novel Amerindian *cagA* and *vacA* alleles in indigenous groups of North and South America.

The most obvious route for human migration to the Americas from Asia was via Beringia - the Bering Land Bridge that existed for hundreds of years while sea levels were low, approximately 13,000 years ago. However, [@B8] suggest that this cannot have been the only way that humans first entered the pre-Columbian Americas. Abundant evidence of parasites such as hookworm (*Ancylostoma duodenale*, *Necator americanus*), whipworm (*Trichuris trichiura*) and threadworm (*Strongyloides stercoralis*) has been identified across the Americas ([@B3], [@B70], [@B9], [@B53]). These parasites are host specific so must have entered the Americas with migrating humans. However, their spread into the New World cannot be explained easily by a migration through Beringia. These parasites need warm moist soils to develop in and to this day do not occur in traditional populations in the Arctic region ([@B9]). None of these parasites could have survived the freezing conditions of the Siberia-Alaska region that humans would have had to pass through if reaching the Americas via the Bering Land Bridge. [@B8] therefore infer that these findings suggest alternative migration routes into the Americas and suggest that some humans (and their parasitic stowaways) arrived via transpacific migration in boats or by coastal migration, possibly through the sub-Arctic region. This area requires further research to understand how this may have happened.

*M. tuberculosis - Dense human populations* - *M. tuberculosis* is a bacterium found across the world. There are a group of closely related pathogenic bacteria known collectively as the *M. tuberculosis* complex. The principle cause of human tuberculosis is *M. tuberculosis sensu stricto*, whereas *Mycobacterium bovis* is the principle cause of tuberculosis in bovids and other animals. *M. tuberculosis* and *M. bovis*evolved from a common ancestor ([@B46]) and genomics indicate that ancestral mycobacteria probably began infecting early hominids in East Africa approximately three million years ago. Modern analyses of *M. tuberculosis* reveal that it is an extremely diverse bacterium and appears to have co-evolved with its human hosts ([@B41], [@B49]). Therefore, *M. tuberculosis*, like *H. pylori*, has been associated with humans for so long its diversity is linked to human migratory history and different strains of the bacterium are associated with different regions of the world.

Tuberculosis was first identified in humans in the pre-colonial Americas, using morphological evidence in a mummified child, dated to approximately 700 AD, from the Nazca culture of Southern Peru ([@B1], [@B43]). This mummy had bone pathology suggestive of tuberculosis and microscopic evidence of acid-alcohol resistant bacilli. Subsequent PCR studies have identified ancient *M. tuberculosis* complex DNA in pre-colonial human remains, thereby confirming its presence prior to European contact. [@B78] were the first to do so using PCR to demonstrate *M. tuberculosis* complex DNA from a hilar lymph node lesion in a 1,000 year-old naturally mummified body from southern Peru. [@B10] successfully used PCR to diagnose tuberculosis in ancient human remains in Chile dated to approximately 1040 AD. The *M. tuberculosis* complex was also detected in North American material from early XI century Mississippi and XV century Canada ([@B20]). These and other studies (i Prat & de Souza 2003) confirm that the *M. tuberculosis* complex was present in the Americas prior to 1492. An early suggestion that these infections were caused by *M. bovis* ([@B28]) was thrown into doubt by the findings of [@B77], who used PCR to detect *M. tuberculosis* complex aDNA from a 17,000 year-old Pleistocene bison metacarpal from Natural Trap Cave, Wyoming. Attempts at typing the aDNA fragments led to the conclusion that the bison tuberculosis was clearly distinct from modern *M. bovis*, but resembled human *M. tuberculosis* or *Mycobacterium africanum*.

The doubts about the existence of tuberculosis in the pre-colonial Americas arose largely because of the great tuberculosis epidemics that raged among indigenous peoples of the Americas after European contact ([@B87]). Such epidemics suggested that these populations had not been exposed to the disease before. It is now suggested that the tuberculosis epidemics that raged among indigenous populations after European contact occurred because of exposure to more virulent European strains of the disease. There is accumulating evidence that ancestral *M. tuberculosis* lineages are less virulent ([@B40]) and it is intriguing to speculate that this also applied to the indigenous tuberculosis in the Americas. However, its genetic characterisation is only now about to be published ([@B19]).

It is interesting to discuss the social structure of the ancient human populations in which *M. tuberculosis* complex DNA has been discovered. The oldest known cases of *M. tuberculosis sensu stricto* were identified by aDNA and skeletal evidence in human remains recovered from a 9,000 year-old Neolithic settlement in the Eastern Mediterranean ([@B50]). This settlement is one of the earliest known human villages with evidence of animal domestication and agriculture. The shift from gatherer-hunters to settled farming communities in the Neolithic period meant that infectious diseases such as tuberculosis that are associated with denser human populations became endemic in agricultural populations from this period onwards. Across the world, the presence of tuberculosis often correlates with the existence of animal domestication because domesticated animals are needed to maintain large human populations and these large populations thereby maintain the tuberculosis. It was previously believed that this correlation existed because humans caught the disease from their animals, but this cannot be the case as *M. tuberculosis* is genetically more ancestral than *M. bovis* ([@B21]).

The Chiribaya population, in which [@B78] found tuberculosis, was agricultural and occupied the Osmore Valley of Peru between approximately 1000-1300 AD. A tuberculosis-like disease was present in prehistoric populations from Northwest Argentina in the XIV-XV centuries. Six of 70 excavated individuals provided evidence of the existence of the disease in the Santa María Valley between the end of the Late Ceramic Period and the onset of the expansion of the Inca Empire ([@B12]). A further study described a case from the Nasca culture from southern Peru dating to about 900 AD ([@B64]). The authors concluded that there was a pandemic level of tuberculosis in the Southern Peruvian coast at this time. The population in Chile, studied by [@B10], was also agricultural. All the skeletons analysed in their paper were dated to 500-1000 AD, which correlates with fully agricultural societies in this region. Agricultural societies are likely places to find tuberculosis because they generally have large populations of people living in close contact. Tuberculosis is a density-dependent disease ([@B16]) that is generally only present in populations such as these.

High population density enables the transmission and maintenance of tuberculosis because it is transmitted between people via the inhalation of infected droplets coughed or sneezed from the lungs of an infected individual. Likelihood of infection therefore increases when people are living in close contact and the chance of the disease being maintained within the population is higher in larger populations ([@B31]). Thus the discovery of tuberculosis in indigenous populations in the Americas provides us with interesting information about the size of these populations. They must have been sufficiently large for the disease to be maintained and the people must have been living in close contact to each other, in order for the disease to be transmitted.

*M. tuberculosis* has been found in North and South America, but strangely, concrete evidence of tuberculosis appears lacking in the ancient Mayan cultures of Mesoamerica. It is probable that the ancient Maya were infected with tuberculosis as their population size was sufficient, they had well established trade routes across the Americas that would have enabled the disease to spread and Mayan art displays individuals that have features characteristic of tuberculosis ([@B65]). Possible reasons for this lack of evidence of tuberculosis have been discussed ([@B65], [@B87]). One explanation may be that persons suffering from tuberculosis were disposed of in a specific way after death that has not yet been discovered by modern archaeologists. [@B87] commented, however, on the very poor state of bone preservation in these remains that may have led to the lack of aDNA data. They also suggested that the particular *M. tuberculosis* genetic lineage in this population was less likely to disseminate from the lung into the bones. It should be noted that in any event, skeletal tuberculosis was extremely rare even in the pre-antibiotic era, with only around 3-5% of infections resulting in visible lesions ([@B76]).

*Souvenir human infectious diseases in the Americas* - When humans first migrated to the Americas they found a landmass already inhabited by wildlife and their pathogens. Many microorganisms that originally infected American wildlife jumped the species barrier and adapted to enable them to cause zoonotic infections in humans. Examples based on historical material or modern genomic studies include bartonellosis or Carrión's disease ([@B2]), mucocutaneous leishmaniasis ([@B27]), Lyme borreliosis ([@B67]), salmonellosis ([@B79]), toxoplasmosis ([@B58]) and treponematosis ([@B66]). Two souvenir diseases are discussed below in more depth, as each gives insight into the environment where pathogens and indigenous peoples interacted.

*T. cruzi - Human living conditions* - Chagas disease exists in the Americas today from southern North America to southern Argentina and causes much human suffering. It is caused by the *T. cruzi* parasite. *T. cruzi* is one of the three major pathogens in the trypanosomatid group. The other pathogens of the group are *Trypanosoma brucei* that causes African sleeping sickness and *Leishmania*spp. The trypanosomatid group consists of very ancient eukaryotic flagellate protozoa of the Kinetoplastida order that have a single flagellum. [@B82] dated the divergence of *T. cruzi* and *T. brucei* to approximately one hundred million years ago, following the separation of the landmasses of Africa, South America and Euroamerica. *T. cruzi* and *T. brucei* have since evolved to become quite different pathogens.

Kinetoplastida are characterised by the presence of kinetoplast DNA near the flagellate's basal body. Kinetoplast DNA is an extra nuclear DNA network of circular molecules that corresponds to the parasite mitochondrial genome ([@B6]). This kinetoplast DNA is extremely useful in the identification of *T. cruzi* in ancient remains. Detection of the kinetoplast DNA is very sensitive due to the high copy number/cell (several thousand) and can readily be achieved by PCR amplification and detection via hybridisation with a probe ([@B45], [@B15]). Evidence for *T. cruzi* can also come from the observation of ancient remains, as the disease can often result in morphological changes such as megacolon - enlargement of the colon ([@B45], [@B75]). Therefore, mummies have been essential to the diagnosis of *T. cruzi* via such morphological observations. Using such methods, ancient *T. cruzi*has been found in ancient human remains across the Americas from Northern Chile ([@B45]) to central Brazil ([@B35]) to North America ([@B75]).

*T. cruzi* is transmitted between its vertebrate hosts via a triatomine insect vector. *T. cruzi* is a very heterogeneous parasite with many different genetic and phenotypic markers, indicating its great diversity. It infects many triatomine insects that act as a vector for parasite transmission between mammals. *T. cruzi* can infect nearly all the tissues of more than one hundred species of mammals. Indeed [@B63] revealed that even within a single mammalian reservoir, great diversity could often be present. Triatomine insects hide inside animal nests/human homes and extract blood from the host while it is sleeping. *T. cruzi* is present in the triatomine faeces, so when the insect bite causes itching the faeces are pushed into the bite wound and the parasite enters the bloodstream and causes infection. The parasite has very little effect on most feral American animals that it infects, suggesting that it has infected these animals for such a long time that they have evolved and adapted to live normally with it. The disease does however often cause premature death in humans, most often as a result of cardiac complications ([@B15]). This indicates the more recent association of humans with this parasite and shorter time to adapt to living with the parasite, as compared to feral animals of the Americas.

Initially it was believed that humans first entered the *T. cruzi* life cycle in the Andean region when triatomine insects became domiciled after the development of urban populations, a sedentary lifestyle and animal domestication ([@B26]). However, it is now thought more likely that humans entered into the zoonotic cycle of *T. cruzi* very soon after entering the Americas ([@B36]) as research indicates that *T. cruzi* was infecting prehistoric indigenous populations long before the development of urban centres in the Andean region. The work of [@B15] revealed that *T. cruzi* has been infecting peoples of the Andean coast for at least 9,000 years and before the development of urban centres in the Andean region. Triatomine insects require some sort of nest to live in, so it may have been the straw bedding of indigenous nomadic populations that first led to humans coming into contact with this parasite. Indigenous urban populations often had houses of wattle and thatch that would again have been ideal nests for triatomine insects. Humans would have been a great new source of food for the triatomine insects and their living conditions, a great new place for protection from climatic changes and predators.

[@B61] used aDNA analyses to show that *T. cruzi* infected both ancient nomadic and urban indigenous peoples of the Americas. They detected *T. cruzi*human infection in Brazil dating back at least 4,500 years, in an individual from a hunter-gatherer population that preceded *T. infestans*domiciliation. The *T. cruzi*I genotype was demonstrated 4,500-7,000 years ago in the state of Minas Gerais, where this genotype is currently absent, suggesting that the distribution pattern of *T. cruzi*genotypes in humans has changed in time and place. *T. cruzi*I is widespread among wild mammals and sylvatic vectors of all biomes. This genotype is commonly isolated from humans and wild mammals in the Amazon Basin today. In contrast, *T. cruzi*II has a focal distribution in nature, but is the main agent of human infection in other Brazilian regions. Further understanding of the exact nesting conditions triatomine insects require may help us learn more about the living conditions of indigenous peoples of the Americas that first put them in contact with this insect.

*Coccidioidomycosis - Human agricultural development* - Coccidioidomycosis, also known as valley fever, is a non-communicable ascomycete fungal disease associated with desert-like areas. The disease is acquired *via* the inhalation of the spores of the fungus, which is found approximately 20 cm beneath the surface of the soil. Today *C. immitis*is found in the San Joaquin Valley, California. The closely related *Coccidioides posadasii*, also known as non-California *C. immitis*, has a wider distribution, being recovered from across the southwestern United States of America, southern California, northern, central and southern Mexico and South America ([@B38]).

*C. immitis* goes through a saprophytic stage and a parasitic stage in its life cycle. The saprophytic stage is a very hardy mould phase that leads to the maturation of the hyphal cells into arthroconidia (rectangular spores). The parasitic phase begins when a human or animal inhales the arthroconidia. Once inside the host lungs the arthroconidia then enlarge to become spherules (spherical double-walled cells). Upon spherule rupture endospores are released that can disseminate in the host and re-initiate the spherulation cycle. This causes a disseminated form of the disease, in which the spherules enter the bloodstream and spread beyond the lungs. Disseminated coccidioidomycosis occurs particularly during pregnancy and is frequently fatal. However, in most cases of infection there are either no symptoms or only minor cold-like symptoms ([@B56]). Strict precautions have to be taken by individuals, such as archaeologists, who are at risk of becoming infected ([@B72]).

*C. immitis* and *C. posadasii* are the only members of this genus capable of causing life-threatening disease in humans and other mammals. Other members of this family live predominantly as plant pathogens, so it is most parsimonious to assume that mammalian virulence was recently and uniquely acquired in *Coccidioides* ([@B80]). It is believed that the common ancestor of *Coccidioides* and non-pathogenic species likely grew on dead or decaying animal matter or on external surfaces of an animal host, such as hair. However, once this association with animals was established, the shift from plant-based to animal-based nutrition ultimately led to disease. The two *Coccidioides*species diverged 5.1 million years ago, well before humans arrived in the New World ([@B71]), so this evolutionary transition to a pathogenic phenotype probably involved mainly rodent hosts and not humans. Some animals, such as mice, now have genes that make them resistant to the disease, which has led to the suggestion that this reflects the prolonged period of time over which *Coccidioides* spp have infected feral American animals ([@B54]).

[@B48] presented the first microscopic evidence of prehistoric human infection with *Cocci- dioides*. They identified human remains in Arizona dated to approximately 1000-1400 AD and therefore belonging to the Sinagua culture. Evidence that the individual had suffered from coccidioidomycosis included the presence of spherules (in the parasitic stage) preserved within the skeleton and the presence of massive widespread lesions suggestive of the disease. Contamination by the fungus after death was ruled out because of the presence of the lesions and the fact that all the fungi present were identified as being in the parasitic stage. This research was carried out before PCR was a widespread technique used in paleomicrobiology, so there were no DNA analyses carried out to confirm the diagnosis. Evidence of ancient cocci- dioidomycosis infection has also been reported by [@B84] in the Los Muertos site in Arizona, which is still an endemic region for coccidioidomycosis today. An ancient adult male of the Hohokum population was found in this region dated to approximately 1150 AD, with lesions suggestive of the disease. Again, the diagnosis is entirely based on the paleopathology of the skeletal lesions.

There was frequent soil contact in prehistoric Hohokum populations in this region because the region contained many irrigation canals that were used to support agriculture ([@B17], [@B84]). Significant construction efforts on the canals took place around the time that this human individual is approximately dated. Digging and maintaining these canals would have placed workers in direct contact with the soil that is the habitat of *Coccidioides* and therefore put workers at risk of infection. Given these circumstances, the fact that people still suffer from coccidioidomycosis in this area today and the skeletal lesions present on the individual, it appears likely that pre-colonial peoples of this region were infected with this fungus. In future, molecular evidence from aDNA analyses should be able to confirm this.

Analysis of microsatellite *loci* from *C. immitis*showed that genetic diversity in this fungus is geographically partitioned throughout North America ([@B37]). In contrast, the South American *C. immitis*population appears to have originated from a single North American population centred in Texas. Genetic analyses show that South American *C. immitis*strains have undergone rapid population growth, consistent with an epidemic increase in post-colonisation population size. [@B37] estimated that the introduction into South America occurred within the last 9,000-140,000 years and noted that this increase in range parallels that of *H. sapiens*. They cited [@B57] who had noted that viable *C. immitis* was strongly associated with Amerindian middens in California and this appeared to be due to the soil alkalinity and past accumulation of domestic contaminants. Because of this, [@B37] suggest that the colonisation of South America by *C. immitis*represents a relatively recent and rapid co-dispersal of a host and its pathogen.

*European contact with the Americas* - What happened subsequent to European discovery of the Americas completely shifted the global distribution of human infectious diseases. Human infectious diseases had evolved independently in the Eastern and Western Hemispheres for thousands of years. Both Hemispheres were home to human populations in which hunting and gathering and the development of agriculture and urban centres were present, yet the geography, climate and native organisms in the hemispheres were different. For these reasons and because of simple chance, there were very different human infectious diseases present in the Eastern and Western Hemispheres ([@B68], [@B22]). Europeans brought many fatal infectious diseases, including smallpox, measles and malaria, to the Americas that had not existed there before, so indigenous peoples of the Americas had no genetic resistance to them. In contrast, Europeans had developed high degrees of immunity to these diseases over the centuries they had been exposed.

The work of [@B16] shows that populations with a long history of urban settlement have greater genetic resistance to tuberculosis. However, another consequence of long-term urbanisation is the development of more virulent strains of pathogens, as transmission is more likely and a large population enables virulent pathogens to persist. This population effect is clearly demonstrated by examining the historical distribution of measles virus in insular communities, where the virus died out once all susceptible individuals had been infected only to recur after the virus was re-introduced ([@B18]). Such findings may explain why the Eastern Hemisphere, that has a longer history of urban settlement, contained more human infectious diseases and more virulent strains of some indigenous pathogens.

During the "period of exploration", a greater number of human infectious diseases were taken to the Americas from Europe than *vice versa*. In addition, considering post-colonial disease epidemiology, the indigenous peoples of the Americas represented a naïve population. The combination of infectious disease, displacement and warfare, brought to America by European colonialism, caused widespread devastation.

Paleomicrobiology is a fast developing area of research that can give us much interesting and useful biological, anthropological, historical and archaeological information. The microbial pathogens described in this review can illuminate the pre-colonial history of the indigenous peoples of the Americas, but raise more questions.

The work on *H. pylori* has provided information about human migrations into the Americas, but highlights the need for much more research. Further investigations should be carried out to consider how ancient human populations could have reached the Americas by sea. Investigating other heirloom infectious diseases in ancient human remains may also facilitate our understanding of migration into the Americas. Further research on *M. tuberculosis*, using hybridisation and DNA capture techniques, for example, may detect tuberculosis in cultures and sites, such as Mesoamerica, where evidence is currently lacking. Investigating which strains of *M. tuberculosis* are present in ancient human remains may tell us about ancient human migrations, but also help answer the question of whether indigenous American strains were significantly different from European strains. If European strains were more virulent this could explain why there was such devastation from tuberculosis post-contact. Research into *T. cruzi* and its insect vector should lead to greater understanding of the living conditions of the indigenous peoples of the Americas that first put them in contact with this insect and parasite. Molecular evidence is required to confirm the existing diagnoses of *C. immitis* and/or *C. posadasii*in the pre-Columbian Americas. Distinction between these two closely related fungi may yield interesting data on their ancient distribution in the environment.

The study of paleomicrobiology enables us to confirm paleopathological diagnoses and to answer historical questions about the extent and impact of human infectious diseases. As has been illustrated above, paleomicrobiology can provide evidence of ancient and historical migrations and indicate the living conditions of past populations. Paleogenomics also can provide real time calibration of genetic changes within pathogens and to link such changes with the society of their human hosts.
